Egetis Therapeutics: Recommendation from the European Thyroid Association - Redeye

Redeye endorses today’s news that the ETA (“European Thyroid Association”) recommends Emcitate as a long-term treatment for MCT8 deficiency and we give a short comment.

Länk till analysen i sin helhet: https://www.redeye.se/research/1022749/egetis-therapeutics-recommendation-from-the-european-thyroid-association?utm_source=finwire&utm_medium=RSS